Ignite Creation Date:
2024-05-06 @ 7:32 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02558387
Status:
UNKNOWN
Last Update Posted:
2015-11-20
First Post:
2015-09-22
Brief Title:
Trial of BIBF1120 Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
Sponsor:
Organization:
Samsung Medical Center